Results 1 to 10 of about 283,567 (361)

Hepatitis C Vaccines, Antibodies, and T Cells [PDF]

open access: yesFrontiers in Immunology, 2018
The development of vaccines that protect against persistent hepatitis C virus (HCV) infection remain a public health priority. The broad use of highly effective direct-acting antivirals (DAAs) is unlikely to achieve HCV elimination without vaccines that ...
Naglaa H. Shoukry, Naglaa H. Shoukry
doaj   +3 more sources

Hepatitis C Virus Evasion Mechanisms from Neutralizing Antibodies [PDF]

open access: yesViruses, 2011
Hepatitis C virus (HCV) represents a major public health problem, affecting 3% of the world’s population. The majority of infected individuals develop chronic hepatitis, which can progress to cirrhosis and hepatocellular carcinoma.
Arvind H. Patel   +2 more
doaj   +4 more sources

Prevalence of hepatitis C in the adult Mexican population: National Survey of Health and Nutrition 2018

open access: yesThe Lancet Regional Health. Americas, 2022
Summary: Background: Hepatitis C is a preventable and treatable disease that has been declared a public health problem. In 2012, the prevalence of HCV serum anti-bodies in the Mexican adult population aged 20 to 49 years was 0·30%.
Martha Carnalla   +10 more
doaj   +1 more source

Predicting factors of present hepatitis C virus infection among patients positive for the hepatitis C virus antibody [PDF]

open access: yesClinical and Molecular Hepatology, 2013
Background/AimsTo identify the predicting factors of present hepatitis C virus (HCV) infection among patients with positivity for antibodies to HCV (anti-HCV).MethodsWe analyzed patients who showed positive enzyme immunoassay (EIA) results and performed ...
Chi Hoon Lee   +10 more
doaj   +1 more source

Serosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDR. [PDF]

open access: yesPLoS ONE, 2015
BACKGROUND AND AIMS:Healthcare workers (HCW) have an increased risk of exposure to infectious diseases and are a potential source of infections for their patients.
Antony P Black   +5 more
doaj   +1 more source

Antibody Responses in Hepatitis C Infection [PDF]

open access: yesCold Spring Harbor Perspectives in Medicine, 2020
Antibody responses in hepatitis C virus (HCV) have been a rather mysterious research topic for many investigators working in the field. Chronic HCV infection is often associated with dysregulation of immune functions particularly in B cells, leading to abnormal lymphoproliferation or the production of autoantibodies that exacerbate inflammation and ...
openaire   +2 more sources

The Role of Specific Cellular Immune System in Chronic Hepatitis C [PDF]

open access: yes, 2004
Hepatitis C virus is a RNA virus with very high speed replication. The clinical course of chronic hepatitis C is frequently asymptomatic like other hepatitis viruses.
Akbar, N. (Nurul)   +4 more
core   +1 more source

Blocking entry of hepatitis B and D viruses to hepatocytes as a novel immunotherapy for treating chronic infections [PDF]

open access: yes, 2021
Background. Chronic hepatitis B and D virus (HBV/HDV) infections can cause cancer. Current HBV therapy using nucleoside analogues (NAs) is life-long and reduces but does not eliminate the risk of cancer.
Ahlén, G   +13 more
core   +1 more source

Interleukins as one of possible markers for early diagnosis of viral hepatitis c at first year old children

open access: yesЖурнал инфектологии, 2014
The article presents the results of the research of improvement one of possible methods of early diagnostics of viral hepatitis C at first-year old children, who born from mothers with chronic viral hepatitis C, in blood anti-HCV IgG are revealed, based ...
T. A. Kirsanova
doaj   +1 more source

Home - About - Disclaimer - Privacy